Allison M. Bock [u6048555] (2024)

Dr. Allison Bock is an Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies. She specializes in treating patients with lymphoma and chronic lymphocytic leukemia. She completed her residency training at University of Colorado and fellowship training in hematology/oncology at Mayo Clinic in Rochester, MN. Her research focuses on improving outcomes for patients with lymphomas through the development of clinical trials with novel therapies and investigation of prognostic/predictive biomarkers including biological pathways and mechanisms that lead to therapy resistance. She is the principal investigator on multiple lymphoma clinical trials at Huntsman Cancer Institute.

• Chronic Lymphocytic Leukemia
• Hematology
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma

★★★★★

5.0 /5

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

See More Patient Comments

Dr. Allison Bock is an Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies. She specializes in treating patients with lymphoma and chronic lymphocytic leukemia. She completed her residency training at University of Colorado and fellowship training in hematology/oncology at Mayo Clinic in Rochester, MN. Her research focuses on improving outcomes for patients with lymphomas through the development of clinical trials with novel therapies and investigation of prognostic/predictive biomarkers including biological pathways and mechanisms that lead to therapy resistance. She is the principal investigator on multiple lymphoma clinical trials at Huntsman Cancer Institute.

Journal Article

1. Bock AM, Mwangi R, Wang Y, Khurana A, Maurer MJ, Ayers A, Kahl BS, Martin P, Cohen JB, Casulo C, Lossos IS, Farooq U, Ayyappan S, Reicks TW, Habermann TM, Witzig TE, Flowers CR, Cerhan JR, Nastoupil LJ, Nowakowski GS (2024). Defining Primary Refractory Large B-cell Lymphoma. Blood Adv. (Read full article)
2. Hines AS, Koster MJ, Bock AR, Go RS, Warrington KJ, Olteanu H, Lasho TL, Patnaik MM, Reichard KK (2022). Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome. Rheumatology (Oxford), 62(12), 3947-3951. (Read full article)
3. Zayac AS, Landsburg DJ, Hughes ME, Bock AM, Nowakowski GS, Ayers EC, Girton M, Hu M, Beckman AK, Li S, Medeiros LJ, Chang JE, Stepanovic A, Kurt H, Sandoval-Sus J, Ansari-Lari MA, Kothari SK, Kress A, Xu ML, Torka P, Sundaram S, Smith SD, Naresh KN, Karimi YH, Epperla N, Bond DA, Farooq U, Saad M, Evens AM, Pandya K, Naik SG, Kamdar M, Haverkos B, Karmali R, Oh TS, Vose JM, Nutsch H, Rubinstein PG, Chaudhry A, Olszewski AJ (2023). High-grade B-cell lymphoma, not otherwise specified: amulti-institutional retrospective study. Blood Adv, 7(21), 6381-6394. (Read full article)
4. Bock AM, Gile JJ, Larson MC, Poonsombudlert K, Tawfiq RK, Maliske S, Maurer MJ, Kabat BF, Paludo J, Inwards DJ, Ayyappan S, Link BK, Ansell SM, Habermann TM, Witzig TE, Nowakowski GS, Cerhan JR, Farooq U, Wang Y (2023). Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood Cancer J, 13(1), 169. (Read full article)
5. Wenzl K, Stokes M, Novak JP, Bock AM, Khan S, Hopper MA, Krull JE, Dropik AR, Walker JS, Sarangi V, Mwangi R, Ortiz M, Stong N, Huang CC, Maurer MJ, Rimsza L, Link BK, Slager SL, Asmann Y, Mondello P, Morin R, Ansell SM, Habermann TM, Feldman AL, King RL, Nowakowski G, Cerhan JR, Gandhi AK, Novak AJ (2023). Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL. (Read full article)
6. Yang F, Long N, Anekpuritanang T, Bottomly D, Savage JC, Lee T, Solis-Ruiz J, Borate U, Wilmot B, Tognon C, Bock AM, Pollyea DA, Radhakrishnan S, Radhakrishnan S, Patel P, Collins RH, Tantravahi S, Deininger MW, Fan G, Druker B, Shinde U, Tyner JW, Press RD, McWeeney S, Agarwal A (2021). Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML. Blood, 139(8), 1208-1221. (Read full article)
7. Simpson HM, Bock A, Cervantes L (2021). Policy in clinical practice: Emergency Medicaid and access to allogeneic stem cell transplant for undocumented immigrants. J Hosp Med, 17(1), 50-53. (Read full article)
8. Canfield GS, Bock A, Mann S, Zimmer S, Somerset H, Franco-Paredes C, Wilson CC, Metter RB (2020). A 31-year-old Micronesian Man With Shoulder Fungating Mass. Clin Infect Dis, 70(5), 973-975. (Read full article)
9. Bock AM, Brunmeier A, Wichman CL, Bergl PA (2017). Encephalopathy With Psychosis Following Group A Streptococcal Sepsis-An Immune-Mediated Phenomenon? Psychosomatics, 58(5), 551-555. (Read full article)
10. Bock AM, LeVeque M, Camitta B, Talano JA (2016). Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 63(12), 2154-2158. (Read full article)
11. Bock A, Chintamaneni K, Rein L, Frazer T, Kayastha G, MacKinney T (2016). Improving pneumococcal vaccination rates of medical inpatients in urban Nepal using quality improvement measures. BMJ Qual Improv Rep, 5(1). (Read full article)
12. Knorr DA, Bock A, Brentjens RJ, Kaufman DS (2013). Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy. Stem Cells Dev, 22(13), 1861-9. (Read full article)
13. Bock AM, Knorr D, Kaufman DS (2013). Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs). J Vis Exp, (74), e50337. (Read full article)
14. Bock AM, Cao Q, Ferrieri P, Young JA, Weisdorf DJ (2012). Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance. Biol Blood Marrow Transplant, 19(1), 102-8. (Read full article)

Review

1. Bock AM, Nowakowski GS, Wang Y (2022). Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment. [Review]. Curr Treat Options Oncol, 23(2), 155-170. (Read full article)

Letter

1. Ng WL, Wang Y, Bock AM, Jevremovic D, Wang ML, Nowakowski GS (2023). Review of management options for mantle cell lymphoma in pregnancy. [Letter to the editor]. Leuk Lymphoma, 64(6), 1194-1198. (Read full article)
2. Bock AM, Pollyea DA (2020). Venetoclax with azacitidine for two younger Jehovah's Witness patients with high risk acute myeloid leukemia. [Letter to the editor]. Am J Hematol. (Read full article)